Note 15 - Segments and Geographic Areas

3 Months Ended

Mar. 31, 2024

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

15. Segments and Geographic Areas

The Company operates in one business segment—the research, development, and sale of medical devices to improve minimally invasive surgery. The Company’s chief operating decision maker (determined to be the Chief Executive Officer) does not manage any part of the Company separately, and the allocation of resources and assessment of performance are based on the Company’s consolidated operating results.

The following table presents long-lived assets (which include property and equipment and operating lease assets) by geographic area:

	March 31, 2024			December 31, 2023
U.S.		28	%		29	%
EMEA		70	%		68	%
Asia		2	%		3	%
Total		100	%		100	%

The following table presents revenue by geographic area based on the country in which the customer is based:

	Three Months Ended March 31,
	2024			2023
US		18	%		21	%
EMEA		66	%		58	%
Asia		16	%		21	%
Total		100	%		100	%

For the three months ended March 31, 2024, the Company had no customer who accounted for more than 10% of revenue. For the three months ended March 31, 2023, the Company had two customers that accounted for 13% and 11% of revenue.